期刊
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY
卷 20, 期 6, 页码 624-630出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/ACI.0000000000000687
关键词
allergen immunotherapy; Co-ordination Group for Mutual Recognition and Decentralised Procedures – Human (CMDh) guideline; in-vivo diagnostics; named-patient products; regulation of allergen products
Purpose of review Key aspects and outcomes from the recently published guidance on the regulation of allergen products are summarized. Recent findings A new regulatory guideline has been published to enhance harmonized national approaches on the regulation of allergen products and thereby strengthen the availability of high-quality products across the European Union (EU). As the guideline was developed, critical aspects for allergen products regulation were identified and are discussed in the document, including recommendations on the regulatory procedures to be applied for diagnostics, allergen immunotherapy products and named-patient products. The new guidance is expected to provide clarifications on and support harmonization of the regulation of allergen products in the EU.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据